Patents, Drug Delivery and Public Health Protection: Health Risk Management for Nanopharmaceuticals
The present article discusses the general risks associated with nanotechnology applications and the deficits of the risk management of engineered nanopharmaceutical particles. An evaluation of the possible health or environmental risks of nanoparticles must systematically be carried out and it is im...
Guardado en:
Autores principales: | da Silva Sant'Anna,Leonardo, Pacheco Ferreira,Aldo, de Menezes Alencar,Maria Simone |
---|---|
Lenguaje: | English |
Publicado: |
Universidad Alberto Hurtado. Facultad de Economía y Negocios
2013
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-27242013000200009 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanopharmaceuticals (Au-NPs) after use: Experiences with a complex higher tier test design simulating environmental fate and effect
por: Kerstin Hund-Rinke, et al.
Publicado: (2021) -
The effects of amine-modified single-walled carbon nanotubes on the mouse microbiota
por: Mulvey JJ, et al.
Publicado: (2018) -
Nanopharmaceuticals (part 1): products on the market
por: Weissig V, et al.
Publicado: (2014) -
Nanopharmaceuticals (part 2): products in the pipeline
por: Weissig V, et al.
Publicado: (2015) -
The significance of urban systems on sustainability and public health
por: Jonathon Taylor, et al.
Publicado: (2021)